… how such investigations have revealed a promising treatment for Rett syndrome: In 2009 the lab showed how a … phase III clinical trials and asked the FDA to approve the treatment. “We expect that IGF-1 peptide, with two methyl …
… neurodegenerative disease. We showed that daily GENUS treatment over several weeks reduced neuroinflammation and … be safe and tolerable in humans and gave encouraging early treatment results such as less brain loss, improved sleep … and by others are exploring the effects of long-term GENUS treatment on cognitive performance as well as brain-imaging- …
… promotes the formation of synapses. They found that this treatment, given two days after the original event took … new synapses between engram cells. A few days after the treatment, mice whose ability to recall the memory had been …
